Greenfield Andrew J 4
4 · ABIOMED INC · Filed Dec 20, 2022
Insider Transaction Report
Form 4
ABIOMED INCNASD
Greenfield Andrew J
VP Healthcare Solutions
Transactions
- Award
Common Stock, $.01 par value
2022-12-16+14→ 15,977 total
Holdings
- 7,000
Stock Option (right to buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 4,896
Stock Option (right to buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying) - 5,000
Stock Option (right to buy)
Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying) - 6,500
Stock Option (right to buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying) - 4,000
Stock Option (right to buy)
Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying) - 2,868
Stock Option (right to buy)
Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying)
Footnotes (3)
- [F1]These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)
- [F2]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F3]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.